KLAC

KLA
D

KLAC

Arincen87/100B

KLA return on equity (ROE)

KLA's return on equity is 80.61%: net income of 5.26B USD over the last twelve months on shareholders' equity of 6.52B USD.

Today
80.61%
Average, 5 years
102.13%
Low, 5 years
73.76%
High, 5 years
237.06%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 5.26B ÷ 6.52B = 80.61%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

Why is KLA's return on equity so high?

Net margin
35.6%
profit on each dollar of sales
Asset turnover
0.76×
sales on each dollar of assets
Equity multiplier
2.83×
assets on each dollar of equity
Return on equity
76.1%
FY2026
  • FY202635.6% × 0.76 × 2.83 = 76.1%
  • FY202533.4% × 0.76 × 3.42 = 86.6%
  • FY202428.1% × 0.64 × 4.58 = 82.0%
  • FY202332.3% × 0.75 × 4.82 = 116.0%
  • FY202236.1% × 0.73 × 8.99 = 237.0%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today80.61%5.26B6.52B
FY202630 Jun 202676.08%4.83B6.35B
FY202530 Jun 202586.56%4.06B4.69B
FY202430 Jun 202482.00%2.76B3.37B
FY202330 Jun 2023116.01%3.39B2.92B
FY202230 Jun 2022237.06%3.32B1.40B
FY202130 Jun 202161.50%2.08B3.38B
FY202030 Jun 202045.58%1.22B2.67B
FY201930 Jun 201944.19%1.18B2.66B
FY201830 Jun 201849.51%802.27M1.62B
FY201730 Jun 201769.82%926.08M1.33B
FY201630 Jun 2016102.22%704.42M689.11M
FY201530 Jun 201586.88%366.16M421.44M
FY201430 Jun 201415.88%582.76M3.67B
FY201330 Jun 201315.60%543.15M3.48B
FY201230 Jun 201222.80%756.02M3.32B
FY201130 Jun 201127.77%794.49M2.86B
FY201030 Jun 20109.45%212.30M2.25B
FY200930 Jun 2009-23.96%-523.37M2.18B
FY200830 Jun 200812.04%359.08M2.98B
FY200730 Jun 200714.88%528.10M3.55B
FY200630 Jun 200610.66%380.45M3.57B
FY200530 Jun 200514.61%445.05M3.05B
FY200430 Jun 20049.27%243.70M2.63B
FY200330 Jun 20036.19%137.19M2.22B
FY200230 Jun 200210.65%216.17M2.03B
FY200130 Jun 20013.79%66.68M1.76B
FY200030 Jun 200014.85%253.80M1.71B
FY199930 Jun 19993.18%39.20M1.23B
FY199830 Jun 199811.20%134.10M1.20B
FY199730 Jun 199710.39%105.40M1.01B
FY199630 Jun 199636.60%196.60M537.20M
FY199530 Jun 199514.50%58.60M404.00M
FY199430 Jun 199413.28%30.20M227.40M
FY199330 Jun 19936.13%7.00M114.10M
FY199230 Jun 1992-13.40%-13.80M103.00M
FY199130 Jun 1991-9.36%-10.60M113.20M
FY199030 Jun 19907.70%9.40M122.10M
FY198930 Jun 198910.54%11.70M111.00M
FY198830 Jun 19889.03%8.80M97.50M
FY198730 Jun 19878.62%7.50M87.00M
FY198630 Jun 198613.10%9.90M75.60M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Dividend yield,Debt to equity,Current ratio,All ratios

Common questions about KLA's ROE

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.